Microbial antagonism: a neglected avenue of natural products research

Progress in Industrial Microbiology

Volumn 35, Issue C, 1999, Pages 27-32

  Burgess, J Grant ^a   Jordan, Elizabeth M ^a   Bregu, Migena ^a   Mearns Spragg, Andrew ^a   Boyd, Kenneth G ^a  

^a HERIOT WATT UNIVERSITY   (United Kingdom)

Author keywords

Antibiotic; Marine epibiotic bacteria; Microbial antagonism

Indexed keywords

EID: 77957059444     PISSN: 00796352     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6352(99)80094-0     Document Type: Article

References (20)

1. Bernan V.S., Greenstein M., and Maiese W.M. Marine micro-organisms as a source of new natural products. Adv. Appl. Microbiol. 43 (1997) 57-89
2. Braithwaite A., and Smith F.J. Chromatographic Methods (1990), Chapman and Hall, London
3. Burkholder P.R., Pfister R.M., and Leitz F.P. Production of a pyrrole antibiotic by a marine bacterium. Appl. Microbiol. 14 (1966) 649-653
4. Burgess J.G., Miyashita H., Sudo H., and Matsunaga T. Antibiotic production by the marine photosynthetic bacterium Chromatium purpuratum NKPB 031704: localization of activity to the chromatophores. FEMS Microbiol. Lett. 84 (1991) 301-306
5. Frieden T.R., Munsiff S.S., Low D.E., Willey B.M., Williams G., Faur Y., Eisner W., Warren S., and Kreiswirth B. Emergence of vancomycin-resistant enterococci in New York city. Lancet 342 (1993) 76-79
6. Gerard J., Haden P., Kelly M.T., and Andersen R.J. Loloatin B, a cyclic decapeptide antibiotic produced in culture by a tropical marine bacterium. Tetrahedron Lett. 37 (1996) 7201-7204
7. Hancock R.E.W. The role of fundamental research and biotechnology in finding solutions to the global problem of antibiotic resistance. Clin. Infect. Dis. 24 Suppl 1 (1997) S148-S150
8. Imamura N., Nishijima M., Takadera T., and Adachi K. New anticancer antibiotics pelagiomicins, produced by a new marine bacterium Pelagiobcter variabilis. J. Antibiot. 50 1 (1997) 8-12
9. Jensen P.R., and Fenical W. Strategies for the discovery of secondary metabolites from marine bacteria: ecological perspectives. Annu. Rev. Microbiol. 48 (1994) 559-584
10. Knowles D.J.C. New strategies for antibacterial drug design. Trends Microbiol. 5 10 (1997) 379-383
11. Leclerc R. Enterococci acquire new kinds of resistance. Clin. Infect. Dis. 24 Suppl 1 (1997) 80-83
12. Lemos M.L., Toranzo A.E., and Barja L.J. Antibiotic activity of epiphytic bacteria isolated from intertidal seaweeds. Microb. Ecol. 11 (1986) 149-163
13. Levy S.B. The challenge of antibiotic resistance. Sci. Am. 278 3 (1998) 32-39
14. McKenzie J.D., and Kelly M.S. A comparative study of sub-cuticular bacteria in brittle stars. Mar. Biol. 120 (1994) 65-80
15. McKenzie J.D., and Grigolava I.V. The echinoderm surface and its role in preventing microfouling. Biofouling 10 1-3 (1996) 261-272
16. Mearns-Spragg A., Boyd K.G., Hubble M.O., and Burgess J.G. Antibiotics from surface-associated marine bacteria. Proceedings of the Fourth Underwater Science Symposium (1997), Society for Underwater Technology, London. 0906940311 147-157
17. Mearns-Spragg A., Bregu M., Boyd K.G., and Burgess J.G. Cross-species induction and enhancement of antimicrobial activity produced by epibiotic bacteria from marine algae and invertebrates, after exposure to terres. Lett. Appl. Microbiol. 27 (1998) 142-146
18. Patterson G.L., and Bolls C.M. Fungal cell-wall polysaccharides elicit an antifungal secondary metabolite (phytoalexin) in the cyanobacterium Scytonema ocellatum. J. Phycol. 33 (1997) 54-60
19. Shiozawa H., Kagasaki T., Kinoshita T., and Haruyama H. Thiomarinol, a new hybrid antimicrobial antibiotic produced by a marine bacterium. J. Antibiot. 46 (1993) 1834-1841
20. Trischman J.A., Tapiolas D.M., Jensen P.R., Dwight R., Fenical W., Mckee T.C., Ireland C.M., Stout T.J., and Clardy J. Salinamide-A and salinamide-B-anti-inflammatory depsipeptides from a marine streptomycete. J. Am. Chem. Soc. 116 (1994) 757-758